AAAAAA

   
Results: 1-13 |
Results: 13
PHASE-II TRIAL OF URACIL TEGAFUR (UFT) PLUS LEUCOVORIN IN PATIENTS WITH ADVANCED PANCREATIC-CARCINOMA - A UNIVERSITY-OF-CHICAGO PHASE-II CONSORTIUM STUDY/
Authors: MANI S KUGLER JW SCIORTINO DF GARCIA JC ANSARI RH HUMERICKHOUSE R MICHELASSI F POSNER MC SHULMAN KL SCHILSKY RL LIST M VOKES EE BENNER S
Citation: S. Mani et al., PHASE-II TRIAL OF URACIL TEGAFUR (UFT) PLUS LEUCOVORIN IN PATIENTS WITH ADVANCED PANCREATIC-CARCINOMA - A UNIVERSITY-OF-CHICAGO PHASE-II CONSORTIUM STUDY/, Annals of oncology, 9(9), 1998, pp. 1035-1037
PHASE-II TRIAL OF PACLITAXEL AND TOPOTECAN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR SUPPORT IN STAGE-IV BREAST-CANCER
Authors: FLEMING GF KUGLER JW HOFFMAN PC ANSARI R BITRAN JD KLEPSCH A MALONE D FASANMADE AA RATAIN MJ VOKES EE
Citation: Gf. Fleming et al., PHASE-II TRIAL OF PACLITAXEL AND TOPOTECAN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR SUPPORT IN STAGE-IV BREAST-CANCER, Journal of clinical oncology, 16(6), 1998, pp. 2032-2037
COMBINED LEVAMISOLE WITH RECOMBINANT INTERLEUKIN-2 (IL-2) IN PATIENTSWITH ADVANCED RENAL-CELL CARCINOMA - A PHASE-II STUDY
Authors: CREAGAN ET HESTORRF RD SUMAN VJ MAILLIARD JA NAIR S KROOK JE KUGLER JW MARSCHKE RF MICHALAK JC TSCHETTER LK
Citation: Et. Creagan et al., COMBINED LEVAMISOLE WITH RECOMBINANT INTERLEUKIN-2 (IL-2) IN PATIENTSWITH ADVANCED RENAL-CELL CARCINOMA - A PHASE-II STUDY, American journal of clinical oncology, 21(2), 1998, pp. 139-141
PILOT-STUDY OF CONTINUOUS-INFUSION 5-FLUOROURACIL, ORAL LEUCOVORIN, AND UPPER-ABDOMINAL RADIATION-THERAPY IN PATIENTS WITH LOCALLY ADVANCEDRESIDUAL OR RECURRENT UPPER GASTROINTESTINAL OR EXTRAPELVIC COLON-CANCER
Authors: MARTENSON JA SWAMINATHAN R BURCH PA SANTALA RG SCHROEDER G PITOT HC WRIGHT K KUGLER JW STELLA PJ GARTON GR
Citation: Ja. Martenson et al., PILOT-STUDY OF CONTINUOUS-INFUSION 5-FLUOROURACIL, ORAL LEUCOVORIN, AND UPPER-ABDOMINAL RADIATION-THERAPY IN PATIENTS WITH LOCALLY ADVANCEDRESIDUAL OR RECURRENT UPPER GASTROINTESTINAL OR EXTRAPELVIC COLON-CANCER, International journal of radiation oncology, biology, physics, 37(3), 1997, pp. 615-618
RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF CISPLATIN AND ETOPOSIDE PLUS MEGESTROL-ACETATE PLACEBO IN EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER - A NORTH CENTRAL CANCER-TREATMENT GROUP-STUDY
Authors: ROWLAND KM LOPRINZI CL SHAW EG MAKSYMIUK AW KUROSS SA JUNG SH KUGLER JW TSCHETTER LK GHOSH C SCHAEFER PL OWEN D WASHBURN JH WEBB TA MAILLIARD JA JETT JR
Citation: Km. Rowland et al., RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF CISPLATIN AND ETOPOSIDE PLUS MEGESTROL-ACETATE PLACEBO IN EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER - A NORTH CENTRAL CANCER-TREATMENT GROUP-STUDY, Journal of clinical oncology, 14(1), 1996, pp. 135-141
PHASE-II TRIALS OF 5-FLUOROURACIL AND LEUCOVORIN IN PATIENTS WITH METASTATIC GASTRIC OR PANCREATIC-CARCINOMA
Authors: RUBIN J GALLAGHER JG SCHROEDER G SCHUTT AJ DALTON RJ KUGLER JW MORTON RF MAILLIARD JA BURCH PA
Citation: J. Rubin et al., PHASE-II TRIALS OF 5-FLUOROURACIL AND LEUCOVORIN IN PATIENTS WITH METASTATIC GASTRIC OR PANCREATIC-CARCINOMA, Cancer, 78(9), 1996, pp. 1888-1891
PHASE-II TRIAL OF METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN IN ADVANCED RECURRENT CARCINOMA OF THE UTERINE CERVIX AND VAGINA
Authors: LONG HJ CROSS WG WIEAND HS WEBB MJ MAILLIARD JA KUGLER JW TSCHETTER LK KARDINAL CG EBBERT LP RAYSON S
Citation: Hj. Long et al., PHASE-II TRIAL OF METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN IN ADVANCED RECURRENT CARCINOMA OF THE UTERINE CERVIX AND VAGINA, Gynecologic oncology, 57(2), 1995, pp. 235-239
PHASE-II EVALUATION OF RECOMBINANT INTERFERON-ALPHA AND BCNU IN RECURRENT GLIOMA
Authors: BUCKNER JC BROWN LD KUGLER JW CASCINO TL KROOK JE MAILLIARD JA KARDINAL CG TSCHETTER LK OFALLON JR SCHEITHAUER BW
Citation: Jc. Buckner et al., PHASE-II EVALUATION OF RECOMBINANT INTERFERON-ALPHA AND BCNU IN RECURRENT GLIOMA, Journal of neurosurgery, 82(3), 1995, pp. 430-435
PLACEBO-CONTROLLED TRIAL OF HYDRAZINE SULFATE IN PATIENTS WITH NEWLY-DIAGNOSED NON-SMALL-CELL LUNG-CANCER
Authors: LOPRINZI CL GOLDBERG RM SU JQ MAILLIARD JA KUROSS SA MAKSYMIUK AW KUGLER JW JETT JR GHOSH C PFEIFLE DM WENDER DB BURCH PA
Citation: Cl. Loprinzi et al., PLACEBO-CONTROLLED TRIAL OF HYDRAZINE SULFATE IN PATIENTS WITH NEWLY-DIAGNOSED NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 12(6), 1994, pp. 1126-1129
PROSPECTIVE EVALUATION OF PROGNOSTIC VARIABLES FROM PATIENT-COMPLETEDQUESTIONNAIRES
Authors: LOPRINZI CL LAURIE JA WIEAND HS KROOK JE NOVOTNY PJ KUGLER JW BARTEL J LAW M BATEMAN M KLATT NE DOSE AM ETZELL PS NELIMARK RA MAILLIARD JA MOERTEL CG
Citation: Cl. Loprinzi et al., PROSPECTIVE EVALUATION OF PROGNOSTIC VARIABLES FROM PATIENT-COMPLETEDQUESTIONNAIRES, Journal of clinical oncology, 12(3), 1994, pp. 601-607
MEASURABLE OR ASSESSABLE DISEASE IN LUNG-CANCER TRIALS - DOES IT MATTER
Authors: JETT JR SU JQ KROOK JE GOLDBERG RM KUGLER JW
Citation: Jr. Jett et al., MEASURABLE OR ASSESSABLE DISEASE IN LUNG-CANCER TRIALS - DOES IT MATTER, Journal of clinical oncology, 12(12), 1994, pp. 2677-2681
PHASE-II EVALUATION OF 5-FLUOROURACIL AND LOW-DOSE LEUCOVORIN IN CISPLATIN-REFRACTORY ADVANCED OVARIAN-CARCINOMA
Authors: LONG HJ NELIMARK RA SU JQ GARNEAU SC LEVITT R GOLDBERG RM POON MA KUGLER JW
Citation: Hj. Long et al., PHASE-II EVALUATION OF 5-FLUOROURACIL AND LOW-DOSE LEUCOVORIN IN CISPLATIN-REFRACTORY ADVANCED OVARIAN-CARCINOMA, Gynecologic oncology, 54(2), 1994, pp. 180-183
RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY FOR ANEMIC CANCER-PATIENTS ON COMBINATION CHEMOTHERAPY
Authors: CASE DC BUKOWSKI RM CAREY RW FISHKIN EH HENRY DH JACOBSON RJ JONES SE KELLER AM KUGLER JW NICHOLS CR SALMON SE SILVER RT STORNIOLO AM WAMPLER GL DOOLEY CM LARHOLT KM NELSON RA ABELS RI
Citation: Dc. Case et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY FOR ANEMIC CANCER-PATIENTS ON COMBINATION CHEMOTHERAPY, Journal of the National Cancer Institute, 85(10), 1993, pp. 801-806
Risultati: 1-13 |